Navigation Links
BBIC – A SOY-based Substance Treats Multiple Sclerosi

Bowmann-Birk Inhibitor Concentrate (BBIC) is a natural soy-based substance. A US based study finds: BBIC improves the condition of animals with a disease similar to multiple// sclerosis.

A group of animals with Autoimmune Encephalomyelitis (EAE) received BBIC, while another group of animals also suffering from the same disease received a placebo.

"Animals that received BBIC were able to walk, while those that didn't get the drug were not," said the study leader Dr. A.M. Rostami, professor and chairperson of the department of Neurology at Jefferson Medical College in Philadelphia.

The animals that received BBIC were able to walk though with some limp or weakness. Although they were’nt completely cured, the results are promising, the researchers said.

It was also found that the CNS of the animals that received BBIC had "significantly less inflammation and demyelination" than animals that hadn't received BBIC.

"It's the first time that BBIC has been used in an EAE model and has shown significant disease suppression, and we hope it can eventually be used in humans," Rostami said.

BBIC inhibits secretion of Proteases, a group of enzymes that are responsible for the inflammation and demyelination associated with multiple sclerosis (MS), a condition which causes inflammation in the myelin coating of nerve fibers.
PRI
'"/>




Page: 1

Related medicine news :

1. Substance abuse linked to adult antisocial syndrome
2. UV- Light Tanning As A Type Of Substance-Related Disorder
3. Homeless People More Prone To Substance Abuse
4. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
5. Using Herbal Products Heightens Substance Abuse Risk in Teens
6. Healthcare Worker Arrested For Administering Noxious Substances
7. Better Screening Now Possible For ADHD In Adult Substance Users
8. More Medicines Found To Contain Toxic Substance
9. Substance P May Pre-empt VIP in Regulating Temperature
10. Fact Sheet on Polonium-210 - The Substance That Killed Former Russian Spy
11. Natural Brain Substance Linked to Parkinsons Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: